Seacalx AS is a pioneering brand that is transforming paradigms in the aquaculture industry. With their groundbreaking product, they offer a sustainable solution to combat salmon lice infections in aquaculture plants. The idea behind Seacalx was initially conceptualized by two researchers at the Institute of Marine Research, who discovered that particulate quicklime (CaO) could effectively treat salmon lice without harming other aquatic organisms.

After years of extensive research and development, Seacalx has now reached a significant milestone in their R&D program. Their unique product is based on specialized production processes and specific particle compositions of calcium oxide. It is applied to net pens using specially designed spreader equipment, ensuring targeted and efficient treatment.

Seacalx provides numerous advantages, including no handling of biomass, no need for starvation before treatment, and an environmentally friendly profile. The calcium oxide used in their product is produced by FMI, Norway's largest lime producer, ensuring top-quality and expertise. Moreover, Seacalx has obtained veterinary medicinal product classification and is in the process of obtaining biocidal product approvals in relevant markets.

As a future supplier of environmentally friendly products, Seacalx prioritizes sustainability. Their product leaves minimal impact on the marine environment and is listed on PLONOR, demonstrating its commitment to preserving our oceans. With their headquarters in Gratangen, Norway, Seacalx is revolutionizing aquaculture practices and paving the way for a healthier and more sustainable industry